JYNT logo

JOINT CORP/THE

JYNTNASDAQ
πŸ† #3247 by market capEarnings Nov 5US Equity
$148.94β–² $3.43 (+2.30%)
Simulated price
1hβ€”
24hβ–² 2.3%
7dβ€”
14dβ€”
30dβ€”
1yβ€”
🏦Market Cap
$122M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-70.6%
Declining
πŸ“ŠGross Margin
80.6%
High
πŸ’΅FCF Margin
7.7%
Moderate
βš–οΈP/S Ratio
2.1x
Cheap
Otter Score
57
Weak
No chart data available for JYNT.

Trading Snapshot

Day Range
$147.66 – $149.76
52-Week Range
$7.50 – $11.26
Volume
$3.09B
Avg Volume
$2.52B
Shares Outstanding
14.3M
Next Earnings
Oct 10, 2026

Fundamentals Snapshot

Annual Revenue
$55M
Last Q Revenue
$15M
P/E Ratio
36.7
P/S Ratio
2.1x
EPS (TTM)
$0.22
Dividend Yield
β€”

Why Investors Own JYNT

  • βœ“High-growth profile β€” revenue up +26.6% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 43% gross margin and 29% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$55Mβ–² +21.0% YoY
Gross Margin (TTM)
42.6%β–² +2.5% YoY
Operating Income (TTM)
$5Mβ–² +21.0% YoY
Free Cash Flow (TTM)
$16Mβ–² +21.0% YoY

About JOINT CORP/THE

The Joint Corp. specializes in the establishment, proprietorship, operation, and overall administration of chiropractic treatment centers. Its business operations are structured into two main divisions: corporate-owned clinics and franchised facilities. The firm employs several strategic models for its expansion and day-to-day functioning, which include direct company ownership, various management agreements, licensing its brand to franchisees, and collaborating with regional development partners. As of March 1, 2022, the company maintained approximately 700 active locations throughout the United States. Founded in 2010, The Joint Corp. maintains its primary corporate headquarters in Scottsdale, Arizona.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
57/100

Analyst Price Target

β“˜
Average Target
$179.22
β–² +20.3% Upside
High Target$215.54
Low Target$136.27
Based on 28 analysts

Latest News & Updates